Jacobs Levy Equity Management, Inc Haemonetics Corp Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $842,595 - $932,337	-10,423 Reduced 5.55%	177,460 $15.1 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $4.02 Million - $5 Million	-55,240 Reduced 22.72%	187,883 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $715,015 - $834,007	-9,682 Reduced 3.83%	243,123 $19.1 Million
Q3 2022 Nov 15, 2022	SELL	$63.3 - $78.66 $1.3 Million - $1.61 Million	-20,477 Reduced 7.49%	252,805 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $12.4 Million - $16.6 Million	251,253 Added 1140.56%	273,282 $17.8 Million
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $964,209 - $1.39 Million	22,029 New	22,029 $1.39 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $381,364 - $624,936	-5,130 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$114.37 - $129.46 $197,860 - $223,965	-1,730 Reduced 25.22%	5,130 $589,000
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $257,752 - $304,744	2,200 Added 47.21%	6,860 $865,000
Q2 2019 Aug 13, 2019	BUY	$81.74 - $120.34 $119,340 - $175,696	1,460 Added 45.63%	4,660 $561,000
Q1 2019 May 14, 2019	SELL	$83.25 - $102.12 $339,743 - $416,751	-4,081 Reduced 56.05%	3,200 $280,000
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $83,407 - $107,299	-920 Reduced 11.22%	7,281 $728,000
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $4.27 Million - $5.44 Million	-47,500 Reduced 85.28%	8,201 $940,000
Q2 2018 Aug 14, 2018	SELL	$71.53 - $95.75 $226,750 - $303,527	-3,170 Reduced 5.38%	55,701 $5 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $3.22 Million - $3.94 Million	53,011 Added 904.62%	58,871 $4.31 Million
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $236,626 - $262,938	5,860	5,860 $263,000

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$448 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$389 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$334 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$316 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$303 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.86B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account